Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

Recently updated phase III trials revealed the favorable effect of add-on procarbazine-lomustine-vincristine chemotherapy (CT) to radiotherapy (RT) in treating anaplastic oligodendrogliomas with 1p19q codeletion (codel). However, the underlying rationality of deferring RT and upfront CT administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Nobuhiro, Yoshimoto, Koji, Hatae, Ryusuke, Kuga, Daisuke, Akagi, Yojiro, Suzuki, Satoshi O, Iwaki, Toru, Shono, Tadahisa, Mizoguchi, Masahiro, Iihara, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119620/
https://www.ncbi.nlm.nih.gov/pubmed/27895504
http://dx.doi.org/10.2147/OTT.S115911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119620/
https://www.ncbi.nlm.nih.gov/pubmed/27895504
http://dx.doi.org/10.2147/OTT.S115911

Ejemplares similares